Jean-Pierre Vuilleumier
Plus aucun poste en cours
Profil
Mr. Jean-Pierre Vuilleumier is Chief Financial Officer at Malcisbo AG.
Mr. Vuilleumier was previously employed as Financial Expert by CTI Start-up and a Managing Director by CTI Invest.
Anciens postes connus de Jean-Pierre Vuilleumier
| Sociétés | Poste | Fin |
|---|---|---|
| CTI Invest | President | - |
CTI Start-up
 CTI Start-up Miscellaneous Commercial ServicesCommercial Services CTI Start-up provides business consulting and business management services. | Corporate Officer/Principal | - |
Malcisbo AG
 Malcisbo AG Pharmaceuticals: MajorHealth Technology Malcisbo AG engages in the development of novel carbohydrate-based vaccines for human and animal health. It specializes in glycoengineering technologies to create novel and efficient glycoconjugate vaccines for unmet needs in human and veterinary medicine targeting large markets. Its vaccines target the medical areas of human Campylobacter infections and and porcine Actinobacillus pleuropneumoniae infections. The company was founded by Bruno Oesch, Irene Schiller, Markus Aebi and Lino Camponovo in May 2010 and is headquartered in Schlieren, Switzerland. | Directeur Financier/CFO | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 3 |
|---|---|
| CTI Invest | |
CTI Start-up
CTI Start-up Miscellaneous Commercial ServicesCommercial Services CTI Start-up provides business consulting and business management services. | Commercial Services |
Malcisbo AG
Malcisbo AG Pharmaceuticals: MajorHealth Technology Malcisbo AG engages in the development of novel carbohydrate-based vaccines for human and animal health. It specializes in glycoengineering technologies to create novel and efficient glycoconjugate vaccines for unmet needs in human and veterinary medicine targeting large markets. Its vaccines target the medical areas of human Campylobacter infections and and porcine Actinobacillus pleuropneumoniae infections. The company was founded by Bruno Oesch, Irene Schiller, Markus Aebi and Lino Camponovo in May 2010 and is headquartered in Schlieren, Switzerland. | Health Technology |
